Compare CYCN & SVRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYCN | SVRN |
|---|---|---|
| Founded | 2018 | 2021 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 17.0M |
| IPO Year | 2019 | 2021 |
| Metric | CYCN | SVRN |
|---|---|---|
| Price | $23.52 | $20.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 114.2K | 111.3K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,074,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $1.03 | $0.16 |
| 52 Week High | $8.48 | $15.12 |
| Indicator | CYCN | SVRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | 83.33 |
| Support Level | $3.04 | $6.17 |
| Resistance Level | $3.42 | N/A |
| Average True Range (ATR) | 0.49 | 1.72 |
| MACD | -0.03 | 0.75 |
| Stochastic Oscillator | 23.67 | 97.53 |
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
Svrn Inc operates in the digital asset and blockchain sector, with a focus on the NEAR Protocol. Its activities include managing a digital asset treasury comprising NEAR, promoting commercial adoption of NEAR-based products, and backing, building, and acquiring ventures that serve its mission.